Alcon (ALC) Competitors

$82.01
+0.55 (+0.68%)
(As of 05/10/2024 ET)

ALC vs. COO, IDXX, CNC, HUM, IQV, HLN, TAK, GEHC, COR, and MRNA

Should you be buying Alcon stock or one of its competitors? The main competitors of Alcon include Cooper Companies (COO), IDEXX Laboratories (IDXX), Centene (CNC), Humana (HUM), IQVIA (IQV), Haleon (HLN), Takeda Pharmaceutical (TAK), GE HealthCare Technologies (GEHC), Cencora (COR), and Moderna (MRNA). These companies are all part of the "medical" sector.

Alcon vs.

Cooper Companies (NASDAQ:COO) and Alcon (NYSE:ALC) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, dividends, earnings, institutional ownership, community ranking and profitability.

Cooper Companies received 435 more outperform votes than Alcon when rated by MarketBeat users. Likewise, 66.67% of users gave Cooper Companies an outperform vote while only 60.92% of users gave Alcon an outperform vote.

CompanyUnderperformOutperform
Cooper CompaniesOutperform Votes
608
66.67%
Underperform Votes
304
33.33%
AlconOutperform Votes
173
60.92%
Underperform Votes
111
39.08%

Cooper Companies has a beta of 0.97, suggesting that its share price is 3% less volatile than the S&P 500. Comparatively, Alcon has a beta of 0.92, suggesting that its share price is 8% less volatile than the S&P 500.

Cooper Companies currently has a consensus target price of $109.48, indicating a potential upside of 15.53%. Alcon has a consensus target price of $91.22, indicating a potential upside of 11.23%. Given Alcon's stronger consensus rating and higher probable upside, equities research analysts clearly believe Cooper Companies is more favorable than Alcon.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cooper Companies
0 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.80
Alcon
2 Sell rating(s)
1 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.64

24.4% of Cooper Companies shares are held by institutional investors. Comparatively, 53.9% of Alcon shares are held by institutional investors. 2.0% of Cooper Companies shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Alcon had 3 more articles in the media than Cooper Companies. MarketBeat recorded 13 mentions for Alcon and 10 mentions for Cooper Companies. Cooper Companies' average media sentiment score of 0.36 beat Alcon's score of 0.36 indicating that Alcon is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cooper Companies
3 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Neutral
Alcon
1 Very Positive mention(s)
4 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

Alcon has higher revenue and earnings than Cooper Companies. Alcon is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cooper Companies$3.59B5.24$294.20M$1.4664.79
Alcon$9.46B4.28$974M$1.9641.84

Alcon has a net margin of 10.30% compared to Alcon's net margin of 7.93%. Alcon's return on equity of 8.79% beat Cooper Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
Cooper Companies7.93% 8.79% 5.65%
Alcon 10.30%6.75%4.63%

Summary

Cooper Companies beats Alcon on 10 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ALC vs. The Competition

MetricAlconOphthalmic goods IndustryMedical SectorNYSE Exchange
Market Cap$40.44B$10.96B$5.18B$17.79B
Dividend YieldN/A1.63%2.86%3.51%
P/E Ratio41.8446.05176.2925.22
Price / Sales4.285.502,314.4411.03
Price / Cash15.1721.3533.9515.59
Price / Book1.963.845.245.10
Net Income$974M$224.33M$105.14M$968.04M
7 Day Performance3.07%-0.41%-0.93%1.48%
1 Month Performance-0.22%-4.82%-2.71%1.00%
1 Year Performance1.70%3.02%2.20%112.19%

Alcon Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COO
Cooper Companies
3.6025 of 5 stars
$93.42
+1.1%
$109.48
+17.2%
-3.0%$18.57B$3.59B63.8815,000Short Interest ↓
IDXX
IDEXX Laboratories
4.1702 of 5 stars
$483.68
+1.4%
$580.88
+20.1%
+5.1%$39.95B$3.66B46.8211,000
CNC
Centene
4.5176 of 5 stars
$75.90
+1.0%
$85.23
+12.3%
+16.3%$40.50B$154.00B15.0967,700
HUM
Humana
4.9968 of 5 stars
$324.63
+1.7%
$424.50
+30.8%
-36.6%$39.12B$106.37B20.2167,600Analyst Revision
IQV
IQVIA
4.7033 of 5 stars
$229.25
+1.0%
$257.57
+12.4%
+24.5%$41.77B$14.98B31.3287,000
HLN
Haleon
2.392 of 5 stars
$8.33
+1.1%
N/A-5.9%$38.04B$14.05B27.7725,408Positive News
TAK
Takeda Pharmaceutical
0.5723 of 5 stars
$13.28
-0.6%
$14.00
+5.4%
-22.0%$42.03B$29.81B20.1249,095News Coverage
GEHC
GE HealthCare Technologies
4.2638 of 5 stars
$81.43
+2.0%
$95.00
+16.7%
+9.9%$36.43B$19.50B23.8151,000Short Interest ↑
COR
Cencora
3.9519 of 5 stars
$226.74
+1.2%
$233.90
+3.2%
+32.5%$45.23B$262.17B24.8146,000
MRNA
Moderna
3.4864 of 5 stars
$121.07
-0.9%
$129.55
+7.0%
-10.3%$46.40B$6.85B-7.735,600Analyst Forecast
Insider Selling

Related Companies and Tools

This page (NYSE:ALC) was last updated on 5/11/2024 by MarketBeat.com Staff

From Our Partners